Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9BYC5: Variant p.Arg337Gly

Alpha-(1,6)-fucosyltransferase
Gene: FUT8
Feedback?
Variant information Variant position: help 337 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Glycine (G) at position 337 (R337G, p.Arg337Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In CDGF1; drastic decrease of protein level in patient's fibroblasts and complete loss of total core fucosylated N-glycans in serum and fibroblasts compared to controls. Any additional useful information about the variant.


Sequence information Variant position: help 337 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 575 The length of the canonical sequence.
Location on the sequence: help VRVHGDPAVWWVSQFVKYLI R PQPWLEKEIEEATKKLGFKH The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         VRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGF-KH

                              VRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGF-N

Chimpanzee                    VRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGF-K

Mouse                         LRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGF-K

Rat                           VRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGF-K

Pig                           VRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGF-K

Bovine                        VRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGF-K

Xenopus tropicalis            IRLHGDPAVWWVSQFVKYLIRPQPWLEKEIEESTKKLGF-K

Caenorhabditis elegans        TSLHSHPPAFFVGTFISYLMRFNSATQEKLDKALKSIPLDK

Drosophila                    KRLHGDPIVWWVGQFLKYLLRPQPTTRDFLTSGMRNLGW-E
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 575 Alpha-(1,6)-fucosyltransferase
Topological domain 31 – 575 Lumenal
Domain 206 – 493 GT23
Alternative sequence 15 – 420 Missing. In isoform 4.
Alternative sequence 330 – 575 Missing. In isoform 2.



Literature citations
Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation.
Ng B.G.; Xu G.; Chandy N.; Steyermark J.; Shinde D.N.; Radtke K.; Raymond K.; Lebrilla C.B.; AlAsmari A.; Suchy S.F.; Powis Z.; Faqeih E.A.; Berry S.A.; Kronn D.F.; Freeze H.H.;
Am. J. Hum. Genet. 102:188-195(2018)
Cited for: INVOLVEMENT IN CDGF1; VARIANTS CDGF1 239-ARG--LYS-575 DEL; 315-ARG--LYS-557 DEL AND GLY-337; FUNCTION; CHARACTERIZATION OF VARIANTS CDGF1 239-ARG--LYS-575 DEL; 315-ARG--LYS-557? DEL AND GLY-337;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.